BASi has developed over 1100 analytical methods. What you see below is only a partial list, those assays we can discuss publicly.
The majority of assays we perform are confidential and proprietary. Our analytical expertise is much broader than this list may
imply, and we are constantly developing additional methods. Be sure to ask if you dont see precisely what
you want on this list.
Search by Test Article
Search is not case-sensitive. Example: mor would return Morphine and Oxymorphone.
This list is updated regularly. Watch for additions and changes.
Therapeutic Category:
Analgesic |
Antidiabetic |
Antibiotic |
Antiviral |
Biomarker |
Cardiac |
Gastric |
Neurology/CNS |
Oncology |
Steroid
List of Antibiotic Related GLP Assays |
updated: 7/7/2010 |
|
|
| Test Article |
Matrix |
Anticoagulant |
Assay Type |
LLOQ |
Isotope IS |
Method # |
| 25-O-Desacetylrifabutin |
Human Plasma |
Heparin |
LC-MS/MS |
1.00 ng/mL |
|
SAP.375 |
| Amoxicillin* |
Human Urine |
N/A |
LC-MS/MS |
100 ng/mL |
|
820-0395 |
| Azithromycin |
Human Plasma |
EDTA |
LC-MS/MS |
TBD ng/mL |
Yes |
SAP.1121 |
| Azithromycin† |
Human Serum |
N/A |
LC-EC |
10.4 ng/mL |
|
SAP.161 |
| Azithromycin† |
Human Plasma |
Heparin |
LC-EC |
12.5 ng/mL |
|
SAP.193 |
| Cefaclor* |
Human Plasma |
Heparin |
LC-UV |
0.250 µg/mL |
|
LC21 |
| Cefditoren |
Human Plasma |
Heparin |
LC-UV |
TBD ng/mL |
|
SAP.804 |
| Cefprozil* |
Human Plasma |
Heparin |
TBD |
TBD ng/mL |
|
SAP.877 |
| Cefuroxime* |
Human Plasma |
Heparin |
LC-UV |
0.200 µg/mL |
|
LC41 |
| Cephalexin* |
Human Plasma |
Heparin |
LC-UV |
0.500 µg/mL |
|
LC45 |
| Ciprofloxacin |
Human Plasma |
EDTA |
LC-MS/MS |
100 ng/mL |
Yes |
SAP.1045 |
| Ciprofloxacin* |
Human Plasma |
Heparin |
LC-FL |
50.0 ng/mL |
|
LC38 |
| Ciprofloxacin |
Rabbit Tissue |
N/A |
LC-MS/MS |
10.0 pg/mL |
Yes |
AP-001-43 |
| Ciprofloxacin* |
Dog Skin |
N/A |
LC-FL |
0.0250 ug/mL |
|
820-0327 |
| Ciprofloxacin* |
Dog Urine |
N/A |
LC-FL |
5000 ng/mL |
|
820-0323 |
| Ciprofloxacin* |
Dog Plasma |
Not Specified |
LC-FL |
50.0 ng/mL |
|
820-0314 |
| Ciprofloxacin* |
Human Serum, BAL, & Pelleted Tissue |
N/A |
LC-MS/MS |
0.500 ng/mL |
|
820-0297 |
| Clarithromycin† |
Human Urine |
N/A |
LC-EC |
195 ng/mL |
|
820-0179 |
| Clarithromycin* |
Human Plasma |
Heparin |
LC-MS/MS |
10.0 ng/mL |
|
LCMS72 |
| Clarithromycin & 14-Hydroxyclarithromycin |
Human Plasma |
Heparin |
LC-MS/MS |
15.6 ng/mL |
|
820-0288 |
| Clarithromycin & 14-Hydroxyclarithromycin* |
Human Urine |
N/A |
LC-MS/MS |
195 ng/mL |
|
820-0290 |
| Danofloxacin*† |
Bovine Plasma |
N/A |
LC-FL |
50.0 ng/mL |
|
820-0333 |
| Demeclocycline* |
Human Plasma |
Heparin |
LC-UV |
0.020 ng/mL |
|
LC53 |
| Difloxacin* |
Dog Plasma |
Not Specified |
LC-FL |
50.0 ng/mL |
|
820-0315 |
| Difloxacin* |
Dog Urine |
N/A |
LC-FL |
0.050 ug/mL |
|
820-0325 |
| Difloxacin* |
Dog Skin |
N/A |
LC-FL |
1.025 ug/mL |
|
820-0329 |
| Doxycycline |
Human Plasma |
EDTA & Heparin |
LC-FL |
TBD ng/mL |
|
SAP.815 |
| Enrofloxacin* |
Dog Skin |
N/A |
LC-FL |
0.0250 ug/mL |
|
820-0327 |
| Enrofloxacin* |
Dog Urine |
N/A |
LC-FL |
0.0500 ug/mL |
|
820-0324 |
| Enrofloxacin* |
Dog Plasma |
Not Specified |
LC-FL |
50.0 ng/mL |
|
820-0312 |
| Erythromycin* |
Human Serum |
N/A |
LC-EC |
15.6 ng/mL |
|
820-0150 |
| Erythromycin |
Human Plasma |
Heparin |
LC-MS/MS |
10.0 ng/mL |
Yes |
SAP.1286 |
| Erythromycin |
Rat & Rabbit Plasma |
Heparin |
LC-MS/MS |
TBD ng/mL |
|
SAP.821 |
| Isoniazid* |
Human Plasma |
Ascorbic Acid & Heparin |
LC-MS/MS |
50.0 ng/mL |
|
LCMS80 |
| Marbofloxacin* |
Dog Skin |
N/A |
LC-FL |
0.0250 ug/mL |
|
820-0326 |
| Marbofloxacin* |
Dog Urine |
N/A |
LC-FL |
0.0500 ug/mL |
|
820-0322 |
| Marbofloxacin* |
Dog Plasma |
Not Specified |
LC-FL |
50.0 ng/mL |
|
820-0313 |
| Moxifloxacin |
Human Plasma |
EDTA |
LC-MS/MS |
50.0 ng/mL |
Yes |
SAP.1046 |
| Nitrofurantoin* |
Human Urine |
N/A |
LC-UV |
0.500 µg/mL |
|
LC42 |
| Nitrofurantoin* |
Human Plasma |
EDTA |
LC-UV |
25.0 ng/mL |
|
LC51 |
| Norfloxacin* |
Human Plasma |
Heparin |
LC-FL |
25.0 ng/mL |
|
LC44 |
| O-Desacetylrifabutin* |
Human Plasma |
Heparin |
LC-MS/MS |
3.75 ng/mL |
|
820-0375 |
| O-Desacetylrifabutin* |
Human Serum & Plasma |
Heparin |
LC-UV |
3.68 ng/mL |
|
820-0222 |
| Ofloxacin* |
Human Plasma |
Heparin |
LC-FL |
50.0 ng/mL |
|
LC40 |
| Rifabutin* |
Human Plasma & Serum |
Heparin |
LC-UV |
5.00 ng/mL |
|
820-0222 |
| Rifabutin* |
Human Plasma |
Heparin |
LC-MS/MS |
3.75 ng/mL |
|
820-0375 |
| Rifabutin |
Human Plasma |
Heparin |
LC-MS/MS |
1.00 ng/mL |
|
SAP.375 |
| Rifampin |
Rabbit Plasma |
Heparin |
LC-MS/MS |
1.00 ng/mL |
|
SAP.1064 |
| Rifampin |
Human Plasma |
Heparin |
LC-MS/MS |
0.200 mg/mL |
|
SAP.058 |
| Rifampin |
Human Plasma |
Heparin |
LC-MS/MS |
0.200 mg/mL |
|
AP-001-58 |
| Rifampin* |
Human Plasma |
EDTA |
LC-UV |
200 ng/mL |
|
820-0554 |
| Sulfamethoxazole* |
Human Serum |
N/A |
LC-MS/MS |
TBD ng/mL |
|
LCMS71 |
| Trimethoprim* |
Human Serum |
N/A |
LC-MS/MS |
0.100 µg/mL |
|
LCMS71 |
| Trovafloxacin*† |
Human Serum, BAL, & Pelleted Tissue |
N/A |
LC-MS/MS |
5.00 ng/mL |
|
820-0318 |
Highlighted items have validation in progress, or exploratory validation work has been
completed.
*May require re-validation to current standards.
†May require third party approval for use of reference or internal standard.
